DFX Intelligence
Data Factory
Reading the graph
Reading the graph
| Class | ||||||||
|---|---|---|---|---|---|---|---|---|
| $69.5M | 5 | 1 | 2028 | |||||
| NEW YORK, | $19B | 2025 | ||||||
| 1 | ||||||||
ROYALTY PHARMA SUB-MANAGER, LLC Registered adviser · RIA / Wealth · 801-132133 Also on Independent Sponsors, Private Equity | NEW YORK, | $20B | 2 | 2025 | ||||
ROYALTY PHARMA US PARTNERS LP Fund · RIA / Wealth · RP MANAGEMENT, LLC Also on Private Credit, Private Equity | $20.6M | 40 | 2012 | |||||
Direct lender | New York, | |||||||
Royalty Pharma Cayman Holdings, LP Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $894M | |||||||
Royalty Pharma Cayman Partners, LP Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $894M | |||||||
| 1 | 1 | 2027 | ||||||
Royalty Pharma Select Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $101M | 2021 | ||||||
Royalty Pharma Cayman Holdings 2008, LP Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $39.9M | 2008 | ||||||
Royalty Pharma Cayman Partners 2008, LP Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $39.9M | 2008 | ||||||
Royalty Pharma US Partners 2008, LP Fund · Private equity · RP Management, LLC Also on Private Credit, RIA / Wealth Management | $21.9M | 2008 |
Ranked by what the graph knows (size, observed deals, people, funds) unless you sort. Size is the best-evidenced figure for the row: AUM or regulatory AUM for firms and offices, close or reported gross asset value for funds, disclosed raised for companies. Click a class or a state in the table to filter by it. Counts are records per graph; with no graph selected, a firm that is on several graphs (matched by CRD, CIK, EIN or fund id, never by name) is listed once, with a dot for each graph.